RhumbLine Advisers’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $117M | Sell |
492,084
-101,321
| -17% | -$21.1M | 0.09% | 188 |
|
|
2026
Q1 | $125M | Sell |
593,405
-13,149
| -2% | -$2.83M | 0.11% | 162 |
|
|
2025
Q4 | $125M | Sell |
606,554
-12,585
| -2% | -$2.37M | 0.1% | 160 |
|
|
2025
Q3 | $97.2M | Sell |
619,139
-274
| -0% | -$42.3K | 0.08% | 204 |
|
|
2025
Q2 | $104M | Sell |
619,413
-41,954
| -6% | -$6.23M | 0.09% | 186 |
|
|
2025
Q1 | $91.1M | Buy |
661,367
+35,312
| +6% | +$4.5M | 0.09% | 204 |
|
|
2024
Q4 | $74M | Sell |
626,055
-20,859
| -3% | -$2.44M | 0.07% | 236 |
|
|
2024
Q3 | $71.5M | Sell |
646,914
-50,630
| -7% | -$5.29M | 0.06% | 255 |
|
|
2024
Q2 | $68.6M | Buy |
697,544
+52,716
| +8% | +$5.37M | 0.06% | 253 |
|
|
2024
Q1 | $72.2M | Buy |
644,828
+80,789
| +14% | +$8.72M | 0.07% | 247 |
|
|
2023
Q4 | $56.9M | Sell |
564,039
-41,707
| -7% | -$4.14M | 0.06% | 286 |
|
|
2023
Q3 | $52.6M | Sell |
605,746
-5,217
| -0.9% | -$472K | 0.06% | 275 |
|
|
2023
Q2 | $57.8M | Buy |
610,963
+21,073
| +4% | +$1.78M | 0.06% | 267 |
|
|
2023
Q1 | $44.5M | Sell |
589,890
-59,351
| -9% | -$4.48M | 0.06% | 316 |
|
|
2022
Q4 | $49.9M | Buy |
649,241
+45,742
| +8% | +$3.48M | 0.07% | 269 |
|
|
2022
Q3 | $40.2M | Buy |
603,499
+28,757
| +5% | +$1.82M | 0.06% | 293 |
|
|
2022
Q2 | $30M | Sell |
574,742
-51,439
| -8% | -$2.92M | 0.04% | 373 |
|
|
2022
Q1 | $35.5M | Buy |
626,181
+9,504
| +2% | +$509K | 0.05% | 349 |
|
|
2021
Q4 | $31.8M | Sell |
616,677
-19,028
| -3% | -$933K | 0.04% | 407 |
|
|
2021
Q3 | $31.4M | Sell |
635,705
-11,457
| -2% | -$622K | 0.04% | 382 |
|
|
2021
Q2 | $36.9M | Sell |
647,162
-16,965
| -3% | -$991K | 0.05% | 341 |
|
|
2021
Q1 | $40.3M | Sell |
664,127
-21,281
| -3% | -$1.17M | 0.05% | 301 |
|
|
2020
Q4 | $36.7M | Buy |
685,408
+11,122
| +2% | +$577K | 0.05% | 319 |
|
|
2020
Q3 | $31.7M | Buy |
674,286
+2,852
| +0.4% | +$146K | 0.05% | 331 |
|
|
2020
Q2 | $35M | Buy |
671,434
+60,555
| +10% | +$3.12M | 0.06% | 296 |
|
|
2020
Q1 | $29.3M | Buy |
610,879
+41,994
| +7% | +$2.18M | 0.06% | 277 |
|
|
2019
Q4 | $28.8M | Buy |
568,885
+26,800
| +5% | +$1.38M | 0.05% | 350 |
|
|
2019
Q3 | $25.6M | Buy |
542,085
+29,291
| +6% | +$1.34M | 0.05% | 367 |
|
|
2019
Q2 | $24.2M | Buy |
512,794
+11,697
| +2% | +$540K | 0.05% | 390 |
|
|
2019
Q1 | $24.1M | Sell |
501,097
-32,152
| -6% | -$1.61M | 0.05% | 371 |
|
|
2018
Q4 | $23.8M | Sell |
533,249
-5,418
| -1% | -$282K | 0.05% | 342 |
|
|
2018
Q3 | $29.1M | Sell |
538,667
-11,759
| -2% | -$602K | 0.06% | 332 |
|
|
2018
Q2 | $26.9M | Sell |
550,426
-16,044
| -3% | -$910K | 0.05% | 345 |
|
|
2018
Q1 | $35.5M | Sell |
566,470
-8,607
| -1% | -$590K | 0.07% | 267 |
|
|
2017
Q4 | $35.2M | Buy |
575,077
+15,549
| +3% | +$961K | 0.07% | 274 |
|
|
2017
Q3 | $37.4M | Buy |
559,528
+13,168
| +2% | +$931K | 0.08% | 251 |
|
|
2017
Q2 | $42.6M | Buy |
546,360
+16,467
| +3% | +$1.24M | 0.1% | 221 |
|
|
2017
Q1 | $43.2M | Buy |
529,893
+4,597
| +0.9% | +$362K | 0.1% | 211 |
|
|
2016
Q4 | $37.8M | Buy |
525,296
+21,485
| +4% | +$1.55M | 0.1% | 218 |
|
|
2016
Q3 | $39.1M | Buy |
503,811
+3,174
| +0.6% | +$257K | 0.11% | 199 |
|
|
2016
Q2 | $39.1M | Buy |
500,637
+16,147
| +3% | +$1.29M | 0.12% | 183 |
|
|
2016
Q1 | $39.7M | Buy |
484,490
+16,471
| +4% | +$1.34M | 0.12% | 165 |
|
|
2015
Q4 | $41.8M | Sell |
468,019
-2,627
| -0.6% | -$223K | 0.13% | 149 |
|
|
2015
Q3 | $36.2M | Buy |
470,646
+4,830
| +1% | +$404K | 0.12% | 168 |
|
|
2015
Q2 | $39M | Buy |
465,816
+32,224
| +7% | +$2.85M | 0.12% | 165 |
|
|
2015
Q1 | $39.1M | Sell |
433,592
-8,430
| -2% | -$726K | 0.11% | 179 |
|
|
2014
Q4 | $35.7M | Buy |
442,022
+1,024
| +0.2% | +$80.9K | 0.1% | 191 |
|
|
2014
Q3 | $33M | Sell |
440,998
-17,794
| -4% | -$1.29M | 0.1% | 196 |
|
|
2014
Q2 | $31.5M | Sell |
458,792
-5,110
| -1% | -$348K | 0.09% | 205 |
|
|
2014
Q1 | $32.5M | Sell |
463,902
-102,105
| -18% | -$7.1M | 0.1% | 194 |
|
|
2013
Q4 | $37.8M | Sell |
566,007
-13,669
| -2% | -$835K | 0.11% | 179 |
|
|
2013
Q3 | $30.2M | Buy |
579,676
+7,219
| +1% | +$367K | 0.09% | 200 |
|
|
2013
Q2 | $27M | Buy |
+572,457
| New | +$26.1M | 0.09% | 219 |
|
Other funds holding CAH
RhumbLine Advisers's CAH Position: Q2 2026 in Review
RhumbLine Advisers reduced its Cardinal Health (CAH) stake by 17% in Q2 2026, selling an estimated $21.1M and leaving 492,084 shares worth $117M. The position accounts for 0.09% of the portfolio, ranked #188.
RhumbLine Advisers first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $125M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- RhumbLine Advisers held 492,084 shares of Cardinal Health worth $117M as of Q2 2026.
- RhumbLine Advisers sold 101,321 Cardinal Health shares in Q2 2026, an estimated $21.1M.
- Cardinal Health made up 0.09% of RhumbLine Advisers's portfolio in Q2 2026, its #188 holding.
- RhumbLine Advisers first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Cardinal Health position peaked at $125M in Q1 2026.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.